Geron Corp (GERN)
3.58
+0.08
(+2.29%)
USD |
NASDAQ |
Apr 24, 16:00
3.55
-0.03
(-0.84%)
After-Hours: 20:00
Geron Total Assets (Quarterly): 394.08M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 394.08M |
September 30, 2023 | 413.02M |
June 30, 2023 | 415.30M |
March 31, 2023 | 424.88M |
December 31, 2022 | 190.58M |
September 30, 2022 | 232.61M |
June 30, 2022 | 238.16M |
March 31, 2022 | 198.42M |
December 31, 2021 | 226.03M |
September 30, 2021 | 229.10M |
June 30, 2021 | 252.18M |
March 31, 2021 | 258.61M |
December 31, 2020 | 270.73M |
September 30, 2020 | 285.79M |
June 30, 2020 | 274.81M |
March 31, 2020 | 142.89M |
December 31, 2019 | 165.52M |
September 30, 2019 | 164.25M |
June 30, 2019 | 166.22M |
March 31, 2019 | 175.67M |
December 31, 2018 | 185.28M |
September 30, 2018 | 187.93M |
June 30, 2018 | 183.27M |
March 31, 2018 | 105.51M |
December 31, 2017 | 110.31M |
Date | Value |
---|---|
September 30, 2017 | 114.24M |
June 30, 2017 | 124.28M |
March 31, 2017 | 128.85M |
December 31, 2016 | 130.25M |
September 30, 2016 | 136.23M |
June 30, 2016 | 137.42M |
March 31, 2016 | 143.14M |
December 31, 2015 | 148.76M |
September 30, 2015 | 154.02M |
June 30, 2015 | 159.08M |
March 31, 2015 | 165.81M |
December 31, 2014 | 172.51M |
September 30, 2014 | 144.25M |
June 30, 2014 | 149.34M |
March 31, 2014 | 155.41M |
December 31, 2013 | 67.34M |
September 30, 2013 | 68.71M |
June 30, 2013 | 73.41M |
March 31, 2013 | 82.85M |
December 31, 2012 | 99.80M |
September 30, 2012 | 111.03M |
June 30, 2012 | 126.19M |
March 31, 2012 | 141.19M |
December 31, 2011 | 160.05M |
September 30, 2011 | 188.40M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
142.89M
Minimum
Mar 2020
424.88M
Maximum
Mar 2023
260.17M
Average
238.16M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 640.55M |
SELLAS Life Sciences Group Inc | 6.219M |
Johnson & Johnson | 167.56B |
Immuneering Corp | 102.58M |
Moderna Inc | 18.43B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 146.13M |
Shareholders Equity (Quarterly) | 247.95M |
Debt to Equity Ratio | 0.3305 |
Current Ratio | 3.159 |
Net Debt Paydown Yield | -0.54% |